BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 20094059)

  • 21. Low-molecular-weight compounds having neurotrophic activity in cultured PC12 cells and neurons.
    Maruoka H; Sasaya H; Sugihara K; Shimoke K; Ikeuchi T
    J Biochem; 2011 Nov; 150(5):473-5. PubMed ID: 21908547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethanol Exposure Regulates
    Bohnsack JP; Patel VK; Morrow AL
    J Pharmacol Exp Ther; 2017 Oct; 363(1):1-11. PubMed ID: 28798030
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of histone deacetylase inhibitors to examine the roles of bromodomain and histone acetylation in p300-dependent gene expression.
    Chen J; Li Q
    Methods Mol Biol; 2013; 977():353-7. PubMed ID: 23436376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.
    Goel A; Janknecht R
    Mol Cell Biol; 2003 Sep; 23(17):6243-54. PubMed ID: 12917345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylation.
    Flodby P; Li C; Liu Y; Wang H; Rieger ME; Minoo P; Crandall ED; Ann DK; Borok Z; Zhou B
    Sci Rep; 2017 Jun; 7(1):3473. PubMed ID: 28615712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
    Kim SN; Kim NH; Lee W; Seo DW; Kim YK
    Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression.
    Wang W; Pan K; Chen Y; Huang C; Zhang X
    Nucleic Acids Res; 2012 Feb; 40(3):981-95. PubMed ID: 21967847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATRA transcriptionally induces nSMase2 through CBP/p300-mediated histone acetylation.
    Clarke CJ; Shamseddine AA; Jacob JJ; Khalife G; Burns TA; Hannun YA
    J Lipid Res; 2016 May; 57(5):868-81. PubMed ID: 27013100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA-dependent dynamic histone acetylation regulates MCL1 alternative splicing.
    Khan DH; Gonzalez C; Cooper C; Sun JM; Chen HY; Healy S; Xu W; Smith KT; Workman JL; Leygue E; Davie JR
    Nucleic Acids Res; 2014 Feb; 42(3):1656-70. PubMed ID: 24234443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition.
    Hogg SJ; Motorna O; Cluse LA; Johanson TM; Coughlan HD; Raviram R; Myers RM; Costacurta M; Todorovski I; Pijpers L; Bjelosevic S; Williams T; Huskins SN; Kearney CJ; Devlin JR; Fan Z; Jabbari JS; Martin BP; Fareh M; Kelly MJ; Dupéré-Richer D; Sandow JJ; Feran B; Knight D; Khong T; Spencer A; Harrison SJ; Gregory G; Wickramasinghe VO; Webb AI; Taberlay PC; Bromberg KD; Lai A; Papenfuss AT; Smyth GK; Allan RS; Licht JD; Landau DA; Abdel-Wahab O; Shortt J; Vervoort SJ; Johnstone RW
    Mol Cell; 2021 May; 81(10):2183-2200.e13. PubMed ID: 34019788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone modifications of Notch1 promoter affect lung CD4+ T cell differentiation in asthmatic rats.
    Cui ZL; Gu W; Ding T; Peng XH; Chen X; Luan CY; Han RC; Xu WG; Guo XJ
    Int J Immunopathol Pharmacol; 2013; 26(2):371-81. PubMed ID: 23755752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcription.
    Kim MK; Shin JM; Eun HC; Chung JH
    PLoS One; 2009; 4(3):e4864. PubMed ID: 19287485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
    Aoyagi S; Archer TK
    Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HDAC inhibition prevents hypobaric hypoxia-induced spatial memory impairment through PΙ3K/GSK3β/CREB pathway.
    Kumar R; Jain V; Kushwah N; Dheer A; Mishra KP; Prasad D; Singh SB
    J Cell Physiol; 2021 Sep; 236(9):6754-6771. PubMed ID: 33788269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Class II HDACs and neuronal regeneration.
    Tang BL
    J Cell Biochem; 2014 Jul; 115(7):1225-33. PubMed ID: 24604703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylases specifically down-regulate p53-dependent gene activation.
    Juan LJ; Shia WJ; Chen MH; Yang WM; Seto E; Lin YS; Wu CW
    J Biol Chem; 2000 Jul; 275(27):20436-43. PubMed ID: 10777477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylases.
    van den Bosch T; Boichenko A; Leus NGJ; Ourailidou ME; Wapenaar H; Rotili D; Mai A; Imhof A; Bischoff R; Haisma HJ; Dekker FJ
    Biochem Pharmacol; 2016 Feb; 102():130-140. PubMed ID: 26718586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.
    Joanna F; van Grunsven LA; Mathieu V; Sarah S; Sarah D; Karin V; Tamara V; Vera R
    J Cell Mol Med; 2009 Sep; 13(9B):2990-3005. PubMed ID: 19583816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.